Posted by Michael Wonder on 27 May 2021
FDA grants Micro Interventional Devices breakthrough device designation for the MIA-T percutaneous tricuspid annuloplasty system
27 May 2021 - Micro Interventional Devices has received breakthrough device designation from the U.S. FDA for its MIA-T percutaneous tricuspid annuloplasty system.
The MIA-T system treats moderate severe tricuspid regurgitation via a 12F catheter-based system.
Read Micro Interventional Devices press release
